Namrata Saroj
Chief Business Officer · OCULAR THERAPEUTIX, INC
IndividualSelling only1 10b5-1 trade
- 2025
- Nov 7, 2025
- 1
Filings (90d)
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Namrata Saroj files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Pravin Dugel - $1.94M in OCUL purchases and sales in the last 12 months
- Richard L. Md Lindstrom - $461K in OCUL purchases and sales in the last 12 months
- Nadia Waheed - $221K in OCUL purchases and sales in the last 12 months
- Donald Notman - $216K in OCUL purchases and sales in the last 12 months
- Jeffrey S. Heier - $204K in OCUL purchases and sales in the last 12 months
- Peter Kaiser - $187K in OCUL purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Namrata Saroj?
Namrata Saroj is a corporate insider, tracked as Chief Business Officer of OCULAR THERAPEUTIX, INC (OCUL). InsiderAlpha holds 1 primary Form 4 filing for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
When did Namrata Saroj last file a Form 4?
The only primary Form 4 on record is dated 7 November 2025.
Has Namrata Saroj been buying or selling stock?
Recorded transactions: 0 open-market purchases and 1 open-market sale ($278K) across all tracked filings.
